BIO UV Group

BIO UV Group

ALTUV · PA · Industrials / Pollution & Treatment Controls

0.84EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.84
Open0.832
Day Range0.832 – 0.87
52-Week Range1.08 – 1.68
Volume8.26K
Market Cap14.64M
P/E (TTM)108.00
Forward P/E0.00
EPS0.01
Dividend Yield0.00%
Beta0.28
50-Day Avg1.29
200-Day Avg1.35

About

BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, Europe, Asia, the Middle East, the United States, and internationally. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services comprising inspection and diagnosis; cleaning and replacement of parts; calibration and adjustments; updates and upgrades; and training and technical support services. The company's products are used in residential and commercial pools, aquariums, aquaculture, industrial water, municipal and domestic water, wastewater and reuse, and ballast water applications. It exports its products. BIO-UV Group S.A. was founded in 2000 and is headquartered in Lunel, France.

Company Details

  • SectorIndustrials
  • IndustryPollution & Treatment Controls
  • CEOMr. Laurent-Emmanuel Migeon
  • Employees143
  • Headquarters850 avenue Louis Médard, Lunel, France, 34400, France
  • Websitehttps://www.bio-uv.com

Leadership

  • Mr. Laurent-Emmanuel MigeonChairman & CEO
  • Mr. Sebastien Marin-LaflecheDirector of Finance
  • Gilles WallezDirector of Operations
  • Mr. Simon MarshallDirector of Sales & Marketing and Director
  • Mr. Xavier BayleR&D Director and Director

Financials

Income Statement

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.62M10.18M12.42M19.98M32.17M33.46M51.29M43.13M39.58M35.90M
Growth (%)-+5.79%+21.95%+60.91%+61.05%+4.00%+53.27%-15.89%-8.24%-9.30%
Cost of Revenue6.07M5.72M7.78M13.55M30.39M31.62M46.58M17.56M15.49M33.92M
Gross Profit3.55M4.46M4.63M6.43M1.78M1.84M4.71M25.58M24.09M2.00M
Gross Margin36.89%43.81%37.32%32.20%5.54%5.50%9.18%59.29%60.87%5.56%
Operating Expense3.89M4.05M4.62M6.74M383.48K841.32K574.95K23.28M21.96M813.73K
Operating Income-343.03K406.03K14.76K-307.35K1.40M997.63K4.13M2.30M2.13M1.18M
Operating Margin-3.56%3.99%0.12%-1.54%4.35%2.98%8.06%5.33%5.39%3.29%
EBITDA959.70K1.07M861.83K1.35M1.71M3.35M6.38M4.43M4.18M1.60M
EBITDA Margin9.97%10.55%6.94%6.74%5.32%10.00%12.43%10.27%10.55%4.46%
Net Income1.28M-91.33K46.31K-448.07K583.95K689.38K2.42M124.89K31.36K836.34K
Net Income Margin13.27%-0.90%0.37%-2.24%1.81%2.06%4.71%0.29%0.08%2.33%
R&D--6511.27K1.48M1.97K2.26M2.89M--
R&D as % of Total Revenue--0.01%0.01%4.60%0.01%4.41%6.71%--
Interest Expense777.40K713.52K287.15K261.54K378.96K364.28K677.44K1.02M775.48K759.78K
Interest Expense % of Total Revenue8.08%7.01%2.31%1.31%1.18%1.09%1.32%2.35%1.96%2.12%

Balance Sheet

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.16M17.88M28.44M36.25M51.92M81.12M74.08M71.41M66.09M69.21M
Total Liabilities11.02M11.88M11.68M20.25M21.72M50.43M41.74M39.19M33.40M28.68M
Total Equity6.09M6.00M16.76M16.00M30.20M30.52M32.24M32.22M32.69M40.47M
Cash1.07M1.01M867.73K1.20M12.57M10.21M1.98M2.73M3.87M8.68M
Total Debt8.37M10.33M6.65M13.54M13.66M30.74M29.15M28.27M23.99M20.23M
Net Debt6.74M7.41M5.78M12.33M1.09M20.52M27.17M25.54M20.12M11.55M

Cash Flow

Currency: EUR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-676.81K1.99M-1.89M-584.54K-121.86K3.30M2.70M6.24M6.90M4.63M
Investing Cash Flow3.53M-3.56M-1.97M-9.95M-3.20M-20.70M-8.95M-1.95M-1.87M-1.60M
Financing Cash Flow-1.20M259.07K8.93M5.90M14.35M15.53M-2.50M-3.57M-3.73M3.37M
Capital Expenditure806.01K3.22M1.97M1.91M3.20M2.73M2.22M1.96M1.90M1.64M
Free Cash Flow-1.48M-1.23M-3.86M-2.49M-3.32M571.69K476.03K4.28M5.00M3.00M
Dividends Paid---505.24K14.35K505.24K505.24K607.07K--
FCF to OCF219.09%-61.97%204.00%426.57%2723.10%17.33%17.65%68.54%72.46%64.80%
Dividend Paid to FCF----20.26%-0.43%88.38%106.14%14.19%--

Earnings

Report DateOct 18, 2018Feb 27, 2019Apr 11, 2019Sep 23, 2019Nov 27, 2019Feb 26, 2020Apr 6, 2020Sep 21, 2020Dec 7, 2020Mar 3, 2021Apr 7, 2021Jul 21, 2021Dec 7, 2021Mar 2, 2022Apr 6, 2022Jul 20, 2022Nov 30, 2022Mar 1, 2023May 26, 2023Jul 19, 2023Nov 29, 2023Apr 3, 2024Sep 20, 2024Nov 27, 2024Apr 29, 2025Sep 18, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.00-0.020.00-0.040.00-0.020.000.080.000.060.000.010.000.220.000.000.000.000.000.000.040.00-0.030.10
Surprise--------------------------
TimingAfter-hours-After-hoursAfter-hours--After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours--After-hoursAfter-hours------

Key Statistics & Ratios

Market Cap14.64M
Enterprise Value27.16M
Trailing P/E108.00
Forward P/E0.00
Price / Sales0.39
Price / Book0.40
EPS0.01
Book Value3.04
Revenue (TTM)37.31M
Gross Profit (TTM)23.34M
EBITDA1.40M
Profit Margin0.50%
Operating Margin5.59%
Return on Equity0.46%
Return on Assets0.60%
Shares Outstanding13.55M
Shares Float13.40M
Beta0.28
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.04Sep 27, 2023
20221×
0.05Jun 28, 2022

Stock Splits

  • Jan 29, 2025870:869